FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Benjamin Scirica

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Marc P Bonaca; Henri Bounameaux; Eugene Braunwald; Mark A Creager; Mikael Dellborg; Jessica M Lamp; Sabina A Murphy; Jeffrey Olin; Benjamin M Scirica; David A Morrow
Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA2{degrees}P-TIMI 50.
Benjamin M Scirica
Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus.
David A Morrow; Sabina A Murphy; Benjamin M Scirica; Mark J Alberts; Sebastian F Ameriso; Marc P Bonaca; Eugene Braunwald; Shinya Goto; Graeme J Hankey; Jay P Mohr
Efficacy and safety of vorapaxar in patients with prior ischemic stroke.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Benjamin Scirica (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marc P Bonaca; Henri Bounameaux; Eugene Braunwald; Mark A Creager; Mikael Dellborg; Jessica M Lamp; Sabina A Murphy; Jeffrey Olin; Benjamin M Scirica; David A Morrow
Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA2{degrees}P-TIMI 50.
Circulation 2013;127(14):1522-9.
2013: Benjamin M Scirica
Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus.
Circulation 2013;127(9):965-7.
2013: David A Morrow; Sabina A Murphy; Benjamin M Scirica; Mark J Alberts; Sebastian F Ameriso; Marc P Bonaca; Eugene Braunwald; Shinya Goto; Graeme J Hankey; Jay P Mohr
Efficacy and safety of vorapaxar in patients with prior ischemic stroke.
Stroke; a journal of cerebral circulation 2013;44(3):691-8.
2013: Dylan L Steen; Christopher P Cannon; Suhas S Lele; Banibrata Mukhopadhyay; Sabina A Murphy; Mohan M Rajapurkar; Benjamin M Scirica; David A Morrow
Prognostic evaluation of catalytic iron in patients with acute coronary syndromes.
Clinical cardiology 2013;36(3):139-45.
2013: Benjamin M Scirica
Therapeutic hypothermia after cardiac arrest.
Circulation 2013;127(2):244-50.
2012: Jacob A Udell; Ph Gabriel Steg; Eugene Braunwald; Jaime Davidson; Boaz Hirshberg; Itamar Raz; Benjamin M Scirica; Deepak L Bhatt
Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus.
Clinical cardiology 2012;35(12):722-9.
2012: Christoph Varenhorst; Lars Wallentin; Nils Åsenblad; Ulrica Alström; Richard C Becker; Gunnar Brandrup-Wognsen; Christopher P Cannon; Charles W Hogue; Jay Horrow; Stefan James; Kenneth W Mahaffey; Benjamin M Scirica; Ph Gabriel Steg; Robert F Storey; Claes Held
Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery.
Journal of the American College of Cardiology 2012;60(17):1623-30.
2012: Benjamin M Scirica; Michal Tendera; Frans Van de Werf; Robert Wilcox; Marc P Bonaca; Eugene Braunwald; Gaetano M De Ferrari; Daniel Isaza; Basil S Lewis; Felix Mehrhof; Piera A Merlini; David A Morrow; Sabina A Murphy; Marc S Sabatine
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial.
Lancet 2012;380(9850):1317-24.
2012: Marc P Bonaca; Eugene Braunwald; Janna S Chamberlin; Petr Jarolim; Sabina A Murphy; Daniel W Rhodes; Marc S Sabatine; Benjamin M Scirica; PC Southwick; David A Morrow
Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes.
Journal of the American College of Cardiology 2012;60(4):332-8.
2012: Jacob A Udell; Deepak L Bhatt; Jang Ik Cho; Kim A Eagle; Shinya Goto; E Magnus Ohman; Benjamin M Scirica; Sidney C Smith; Philippe Gabriel STEG
Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis.
Archives of internal medicine 2012;172(14):1086-95.
2012: Ragnhild Røysland; Marc Sabatine; Benjamin M Scirica; Sabina A Murphy; Torbjørn Omland; Mette Bjerre; Marc P Bonaca; Eugene Braunwald; Allan Flyvbjerg; David A Morrow
Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes.
Heart (British Cardiac Society) 2012;98(10):786-91.
2012: Chih-Chun Chia; Hitinder S Gurm; Sean McMillan; Ilan Rubinfeld; Benjamin M Scirica; Zeeshan Syed
Looking beyond historical patient outcomes to improve clinical models.
Science translational medicine 2012;4(131):131ra49.
2012: David A Morrow; Sabina A Murphy; José Carlos Nicolau; A J Oude Ophuis; Ernesto Paolasso; Benjamin M Scirica; Jindrich Spinar; John Strony; Pierre Theroux; Stephen D Wiviott; Sebastian F Ameriso; Marc P Bonaca; Eugene Braunwald; Anthony J Dalby; Mary Polly Fish; Keith A A Fox; Leslie J Lipka; Xuan Liu
Vorapaxar in the secondary prevention of atherothrombotic events.
The New England journal of medicine 2012;366(15):1404-13.
2011: Jessica L Mega; Alan D Michelson; Michael J Pencina; William J Rogers; Christian T Ruff; Benjamin M Scirica; Dominick J Angiolillo; Charles Contant; Andrew L Frelinger; Willibald Hochholzer; Steven Isserman; Dean J Kereiakes; Michael J Kluk; Janina A Longtine; Marc S Sabatine
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease.
JAMA : the journal of the American Medical Association 2011;306(20):2221-8.
2011: James R Harkness; J Lopez-Sendon; David A Morrow; Fang Ren; Christopher Bode; Eugene Braunwald; Andrzej Budaj; Benjamin M Scirica
Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial).
The American journal of cardiology 2011;108(10):1373-81.
2011: Benjamin M Scirica; Ph Gabriel Steg; Jacob Udell; Deepak L Bhatt; Eugene Braunwald; Roland Chen; Jaime Davidson; Boaz Hirshberg; Peter Ohman; Deborah L Price; Itamar Raz
The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study.
American heart journal 2011;162(5):818-825.e6.
2011: Mitul B Kadakia; Marc P Bonaca; Caroline S Fox; Sabina A Murphy; Benjamin M Scirica; David A Morrow
Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial.
Heart (British Cardiac Society) 2011;97(21):1782-7.
2011: Zeeshan Syed; Benjamin M Scirica; Collin M Stultz; John V Guttag
Computationally generated cardiac biomarkers for risk stratification after acute coronary syndrome.
Science translational medicine 2011;3(102):102ra95.
2011: Jonathan W Waks; Benjamin M Scirica
Established and novel biomarkers in ST-elevation myocardial infarction.
Future cardiology 2011;7(4):523-46.
2011: Babak Nazer; Kausik K Ray; Sarah Sloan; Benjamin M Scirica; David A Morrow; Christopher P Cannon; Eugene Braunwald
Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome.
European heart journal 2011;32(11):1390-7.
2011: Farhad Abtahian; Benjamin Olenchock; Fang-Shu Ou; Michael C Kontos; Jorge F Saucedo; Benjamin M Scirica; Nihar Desai; Eric Peterson; Matthew Roe; Christopher P Cannon; Stephen D Wiviott
Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry).
The American journal of cardiology 2011;107(10):1441-6.
2011: Benjamin M Scirica; Christopher P Cannon; Håkan Emanuelsson; Eric L Michelson; Robert A Harrington; Steen Husted; Stefan James; Hugo Katus; Prem Pais; Dimitar Raev; Jindrich Spinar; Ph Gabriel Steg; Robert F Storey; Lars Wallentin
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy.
Journal of the American College of Cardiology 2011;57(19):1908-16.
2011: Benjamin M Scirica; Marc S Sabatine; Petr Jarolim; Sabina A Murphy; James L de Lemos; Eugene Braunwald; David A Morrow
Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.
European heart journal 2011;32(6):697-705.
2011: Claes Held; Nils Asenblad; Jean-Pierre Bassand; Richard C Becker; Christopher P Cannon; Marc J Claeys; Robert A Harrington; Jay Horrow; Steen Husted; Stefan K James; Kenneth W Mahaffey; José C Nicolau; Benjamin M Scirica; Robert F Storey; Marius Vintila; Joseph Ycas; Lars Wallentin
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.
Journal of the American College of Cardiology 2011;57(6):672-84.
2010: Paul M Szumita; Steven A Baroletti; Kathleen Ryan Avery; Anthony F Massaro; Peter C Hou; Carol Daddio Pierce; Galen V Henderson; Peter H Stone; Benjamin M Scirica
Implementation of a Hospital-wide Protocol for Induced Hypothermia Following Successfully Resuscitated Cardiac Arrest.
Critical pathways in cardiology 2010;9(4):216-20.
2010: Deepak L Bhatt; Byron L Cryer; Charles F Contant; Marc Cohen; Angel Lanas; Thomas J Schnitzer; Thomas L Shook; Pablo Lapuerta; Mark A Goldsmith; Loren Laine; Benjamin M Scirica; Sabina A Murphy; Christopher P Cannon
Clopidogrel with or without omeprazole in coronary artery disease.
The New England journal of medicine 2010;363(20):1909-17.
2010: Mitul B Kadakia; Nihar R Desai; Karen P Alexander; Anita Y Chen; JoAnne M Foody; Christopher P Cannon; Stephen D Wiviott; Benjamin M Scirica
Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines).
JACC. Cardiovascular interventions 2010;3(11):1166-77.
2010: Benjamin M Scirica; Eugene Braunwald; Luiz Belardinelli; Chester M Hedgepeth; Jindrich Spinar; Whedy Wang; Jie Qin; Ewa Karwatowska-Prokopczuk; Freek W A Verheugt; David A Morrow
Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial.
Circulation 2010;122(5):455-62.
2010: Benjamin M Scirica; David A Morrow; Christoph Bode; Witold Ruzyllo; Mikhail Ruda; Anthonius J M Oude Ophuis; Jose Lopez-Sendon; Karl Swedberg; Michal Ogorek; Nader Rifai; Valentina Lukashevich; Mojdeh Maboudian; Christopher P Cannon; Carolyn H McCabe; Eugene Braunwald
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.
European heart journal 2010;31(16):1993-2005.
2010: Renato D Lopes; Eric D Peterson; Anita Y Chen; Matthew T Roe; Tracy Y Wang; E Magnus Ohman; David J Magid; P Michael Ho; Stephen D Wiviott; Benjamin M Scirica; Karen P Alexander
Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry.
JACC. Cardiovascular interventions 2010;3(6):669-77.
2010: Matthew W Sherwood; David A Morrow; Benjamin M Scirica; Songtao Jiang; Christoph Bode; Nader Rifai; Robert E Gerszten; C Michael Gibson; Christopher P Cannon; Eugene Braunwald; Marc S Sabatine
Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28.
American heart journal 2010;159(6):964-971.e1.
2010: Marc Bonaca; Benjamin M Scirica; Marc S Sabatine; Anthony Dalby; Jindrich Spinar; Sabina A Murphy; Petr Jarolim; Eugene Braunwald; David A Morrow
Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
Journal of the American College of Cardiology 2010;55(19):2118-24.
2010: Mauricio G. Cohen; Mario Pascual; Benjamin M Scirica; E Magnus Ohman
Therapeutic goals in patients with refractory chronic angina.
Revista española de cardiología 2010;63(5):571-82.
2010: Jessica L Mega; Judith S Hochman; Benjamin M Scirica; Sabina A Murphy; Sarah Sloan; Carolyn H McCabe; Piera Merlini; David A Morrow
Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36).
Circulation 2010;121(16):1809-17.
2010: Benjamin M Scirica
Acute coronary syndrome: emerging tools for diagnosis and risk assessment.
Journal of the American College of Cardiology 2010;55(14):1403-15.
2010: David A Morrow; Benjamin M Scirica; Marc S Sabatine; James A de Lemos; Sabina A Murphy; Petr Jarolim; Pierre Theroux; Christophe Bode; Eugene Braunwald
B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial.
Journal of the American College of Cardiology 2010;55(12):1189-96.
2010: James R Harkness; Marc S Sabatine; Eugene Braunwald; David A Morrow; Sarah Sloan; Stephen D Wiviott; Robert P Giugliano; Elliott M Antman; Christopher P Cannon; Benjamin M Scirica
Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction.
American heart journal 2010;159(1):55-62.
2009: Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel STEG; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
The New England journal of medicine 2009;361(11):1045-57.
2009: David A Morrow; Benjamin M Scirica; Keith A A Fox; Gail Berman; John Strony; Enrico Veltri; Marc P Bonaca; Polly Fish; Carolyn H McCabe; Eugene Braunwald
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial.
American heart journal 2009;158(3):335-341.e3.
2009: C Michael Gibson; Yuri B Pride; Jacqueline Buros; Lauren N Ciaglo; David A Morrow; Benjamin M Scirica; Peter H Stone
Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis).
The American journal of cardiology 2009;104(1):36-40.
2009: David A Morrow; Stephen D Wiviott; Harvey D White; Jose C Nicolau; Ezio Bramucci; Sabina A Murphy; Marc P Bonaca; Christian T Ruff; Benjamin M Scirica; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Circulation 2009;119(21):2758-64.
2009: Sean R Wilson; Benjamin M Scirica; Eugene Braunwald; Sabina A Murphy; Ewa Karwatowska-Prokopczuk; Jacqueline Buros; Bernard R Chaitman; David A Morrow
Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
Journal of the American College of Cardiology 2009;53(17):1510-6.
2009: Benjamin M Scirica; David A Morrow; Andrzej Budaj; Anthony J Dalby; Satishkumar Mohanavelu; Jie Qin; Julian Aroesty; Chester M Hedgepeth; Peter H Stone; Eugene Braunwald
Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
Journal of the American College of Cardiology 2009;53(16):1411-21.
2009: David A Morrow; Benjamin M Scirica; Bernard R Chaitman; Darren K McGuire; Sabina A Murphy; Ewa Karwatowska-Prokopczuk; Carolyn H McCabe; Eugene Braunwald
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial.
Circulation 2009;119(15):2032-9.
2009: Zeeshan Syed; Phil Sung; Benjamin M Scirica; David A Morrow; Collin M Stultz; John V Guttag
Spectral energy of ECG morphologic differences to predict death.
Cardiovascular engineering (Dordrecht, Netherlands) 2009;9(1):18-26.
2009: Zeeshan Syed; Benjamin M Scirica; Satishkumar Mohanavelu; Phil Sung; Eric L Michelson; Christopher P Cannon; Peter H Stone; Collin M Stultz; John V Guttag
Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphology.
The American journal of cardiology 2009;103(3):307-11.
2009: Benjamin M Scirica; Christopher P Cannon; Marc S Sabatine; Petr Jarolim; Sarah Sloane; Nader Rifai; Eugene Braunwald; David A Morrow
Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death.
Clinical chemistry 2009;55(2):265-73.
2009: Benjamin M Scirica
Chronic angina: definition, prevalence, and implications for quality of life.
Reviews in cardiovascular medicine 2009;10 Suppl 1():S3-10.
2008: Suzanne V Arnold; David A Morrow; Kaijun Wang; Yang Lei; Elizabeth M Mahoney; Benjamin M Scirica; Eugene Braunwald; David J Cohen
Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
Circulation. Cardiovascular quality and outcomes 2008;1(2):107-15.
2008: Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Ivan Horvath; Mátyás Keltai; Jean-Paul R Herrman; Frans Van de Werf; William E Downey; Benjamin M Scirica; Sabina A Murphy; Elliott M Antman
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
Lancet 2008;371(9621):1353-63.
2007: Robert W Yeh; Stephen D Wiviott; Robert P Giugliano; David A Morrow; Amy Shui; Jie Qin; Benjamin M Scirica; James E Bradner; Ik-Kyung Jang; C Michael Gibson; Elliott M Antman
Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes.
The American journal of cardiology 2007;100(12):1734-8.
2007: Christopher P Cannon; Steen Husted; Robert A Harrington; Benjamin M Scirica; Håkan Emanuelsson; Gary Peters; Robert F Storey
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.
Journal of the American College of Cardiology 2007;50(19):1844-51.
2007: Benjamin M Scirica; David A Morrow; Hanoch Hod; Sabina A Murphy; Luiz Belardinelli; Chester M Hedgepeth; Peter Molhoek; Freek W A Verheugt; Bernard J Gersh; Carolyn H McCabe; Eugene Braunwald
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.
Circulation 2007;116(15):1647-52.
2007: Benjamin M Scirica; David A Morrow; Christopher P Cannon; James A de Lemos; Sabina Murphy; Marc S Sabatine; Stephen D Wiviott; Nader Rifai; Carolyn H McCabe; Eugene Braunwald
Clinical application of C-reactive protein across the spectrum of acute coronary syndromes.
Clinical chemistry 2007;53(10):1800-7.
2007: Benjamin M Scirica
Ranolazine in patients with coronary artery disease.
Expert opinion on pharmacotherapy 2007;8(13):2149-57.
2007: Benjamin M Scirica; David A Morrow; Zygmunt Sadowski; Mikhail Ruda; José Carlos Nicolau; Robert P Giugliano; Stephen D Wiviott; Marc S Sabatine; Amy Shui; Elliott M Antman; Eugene Braunwald
A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study.
European heart journal 2007;28(17):2070-6.
2007: Benjamin M Scirica; David A Morrow
Ranolazine in patients with angina and coronary artery disease.
Current cardiology reports 2007;9(4):272-8.
2007: David A Morrow; Benjamin M Scirica; Ewa Karwatowska-Prokopczuk; Sabina A Murphy; Andrzej Budaj; Sergei Varshavsky; Andrew A Wolff; Allan M Skene; Carolyn H McCabe; Eugene Braunwald
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
JAMA : the journal of the American Medical Association 2007;297(16):1775-83.
2007: Marc P Bonaca; Stephen D Wiviott; Marc S Sabatine; Jacqueline Buros; Sabina A Murphy; Benjamin M Scirica; Nader Rifai; Elliott M Antman; David A Morrow
Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
The American journal of cardiology 2007;99(3):344-8.
2006: Benjamin M Scirica; Christopher P Cannon; Richard Cooper; Richard H Aster; Jacqueline Brassard; Carolyn H McCabe; Andrew Charlesworth; Allan M Skene; Eugene Braunwald
Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial.
Journal of thrombosis and thrombolysis 2006;22(2):95-102.
2006: C Michael Gibson; Ajay J Kirtane; David A Morrow; Theresa M Palabrica; Sabina A Murphy; Peter H Stone; Benjamin M Scirica; Lisa K Jennings; Howard C Herrmann; David J Cohen; Carolyn H McCabe; Eugene Braunwald
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
American heart journal 2006;152(4):756-61.
2006: David M Charytan; Laura Mauri; Anupam Agarwal; Steven Servoss; Benjamin M Scirica; Richard E Kuntz
The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients.
American heart journal 2006;152(3):558-64.
2006: Benjamin M Scirica; Marc S Sabatine; David A Morrow; C Michael Gibson; Sabina A Murphy; Stephen D Wiviott; Robert P Giugliano; Carolyn H McCabe; Christopher P Cannon; Eugene Braunwald
The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study.
Journal of the American College of Cardiology 2006;48(1):37-42.
2006: Benjamin M Scirica; David A Morrow; Christopher P Cannon; Kausik K Ray; Marc S Sabatine; Petr Jarolim; Amy Shui; Carolyn H McCabe; Eugene Braunwald
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.
Journal of the American College of Cardiology 2006;47(11):2326-31.
2006: David A Morrow; Benjamin M Scirica; Ewa Karwatowska-Prokopczuk; Allan M Skene; Carolyn H McCabe; Eugene Braunwald
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
American heart journal 2006;151(6):1186.e1-9.
2006: Benjamin M Scirica; David A Morrow
Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out.
Circulation 2006;113(17):2128-34; discussion 2151.
2006: Benjamin M Scirica; Patrick T O'Gara
Valvular heart disease in pregnancy.
Current cardiology reports 2006;8(2):83-9.
2006: Benjamin M Scirica; David A Morrow
Appropriate invasive and conservative treatment approaches for patients with non-ST-elevation MI.
Current treatment options in cardiovascular medicine 2006;8(1):13-21.
2005: Benjamin M Scirica; Christopher P Cannon
Treatment of elevated cholesterol.
Circulation 2005;111(21):e360-3.
2005: Marc S Sabatine; Gavin J Blake; Mark H Drazner; David A Morrow; Benjamin M Scirica; Sabina A Murphy; Carolyn H McCabe; William S Weintraub; C Michael Gibson; Christopher P Cannon
Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment.
Circulation 2005;111(10):1217-24.
2004: Benjamin M Scirica; David A Morrow
Troponins in acute coronary syndromes.
Progress in cardiovascular diseases 2004;47(3):177-88.
2003: Benjamin M Scirica; David A Morrow
Troponins in acute coronary syndromes.
Seminars in vascular medicine 2003;3(4):363-74.
2002: Benjamin M Scirica; Christopher P Cannon; Carolyn H McCabe; Sabina A Murphy; H Vernon Anderson; William J Rogers; Peter H Stone; Eugene Braunwald
Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification.
The American journal of cardiology 2002;90(8):821-6.
2002: Benjamin M Scirica; Christopher P Cannon; C Michael Gibson; Sabina A Murphy; David J Moliterno; H Vernon Anderson; FV Aguirre; Christopher B Granger; Costas T Lambrew; LeRoy E Rabbani; Shelly K Sapp; Joan E Booth; James J Ferguson; Eugene Braunwald
Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries.
Critical pathways in cardiology 2002;1(3):150-8.
2002: Benjamin M Scirica; Christopher P Cannon; Elliott M Antman; Sabina A Murphy; David A Morrow; Marc S Sabatine; Carolyn H McCabe; C Michael Gibson; Eugene Braunwald
Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry.
The American journal of cardiology 2002;90(3):303-5.
1999: Benjamin M Scirica; David J Moliterno; Nathan R Every; H V Anderson; FV Aguirre; Christopher B Granger; Costas T Lambrew; L E Rabbani; Shelly K Sapp; Joan E Booth; James J Ferguson; Christopher P Cannon
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry.
American heart journal 1999;138(6 Pt 1):1065-72.
1999: Benjamin M Scirica; David J Moliterno; Nathan R Every; H Vernon Anderson; FV Aguirre; Christopher B Granger; Costas T Lambrew; L E Rabbani; A Arnold; Shelly K Sapp; Joan E Booth; James J Ferguson; Christopher P Cannon
Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators.
The American journal of cardiology 1999;84(10):1145-50.
1999: Christopher P Cannon; E B Johnson; M Cermignani; Benjamin M Scirica; Mark J Sagarin; Ron M Walls
Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction.
Clinical cardiology 1999;22(1):17-20.
1998: Mark J Sagarin; Christopher P Cannon; M S Cermignani; Benjamin M Scirica; Ron M Walls
Delay in thrombolysis administration: causes of extended door-to-drug times and the asymptote effect.
The Journal of emergency medicine 1998;16(4):557-65.